Abacavir and Lamivudine PK in Children

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
HIV
Interventions
DRUG

abacavir

Dosing of ABC will be according to the WHO guidelines by weight band for twice daily dosing. The once daily dosing will use the same mg/day as the twice daily dosing for that weight band

DRUG

3TC

Dosing of 3TC will be according to the WHO guidelines by weight band for twice daily dosing. The once-daily dosing will use the same mg/day as the twice-daily dosing for that weight band

Trial Locations (1)

10330

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

collaborator

amfAR, The Foundation for AIDS Research

OTHER

collaborator

PHPT/AMS Laboratory, Faculty of Associated Medical Sciences, Chiang Mai University

UNKNOWN

collaborator

Chulalongkorn University

OTHER

collaborator

ViiV Healthcare

INDUSTRY

lead

The HIV Netherlands Australia Thailand Research Collaboration

OTHER